Indefinite Delivery Contract SPE2D225D0007
Award Date
2/13/25
Last Date to Order
2/12/30
Federal Agency
Medical Supply Chain
Awardee
Specgx LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned for-profit pharmaceutical manufacturer. The contract, valued at $5,892,883.55, was awarded on September 27, 2024 by the Defense Logistics Agency (DLA) and has an ultimate completion date of September 26, 2029. Under this IDC, Specgx primarily provides the Department of Veterans Affairs (VA), Department of Defense, Bureau of...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned, for-profit pharmaceutical manufacturer. The $7.3 million contract is for the supply of oxycodone HCL-acetaminophen tablets in various strengths and package sizes to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The...
The Indefinite Delivery Contract (IDC) SPE2D222D0147 was awarded by the Defense Logistics Agency (DLA) to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC has a total ceiling value of $10,967,220.00 and a period of performance running through September 13, 2027. Under this contract, Mylan will provide the DLA, Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service with a variety of...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Illinois. The single-award contract, valued up to $499,999,999, runs through December 31, 2025 and is part of the DLA's SPE2DB program. Under this IDC, DMS Pharmaceutical Group will provide a broad range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities supported by DLA...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 single-award IDC, under the SPE2DB program, runs through December 31, 2025 and allows DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The IDC covers a vast array...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The single-award IDC, valued up to $499,999,999, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. Key items included under this IDC span multiple therapeutic categories, such as naltrexone tablets, botulinum toxin...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Illinois. The $499,999,999 single-award IDC, valid through December 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The IDC covers an extensive portfolio of branded and generic...
This single-award Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The IDC covers a comprehensive portfolio of...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award IDC, valued at up to $499,999,999, runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The...
This indefinite delivery contract (IDC) was awarded by the U.S. Defense Logistics Agency (DLA) to the woman-owned small business DMS Pharmaceutical Group Inc. The single-award IDC, valued up to $499,999,999, provides the DLA with a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this IDC vehicle, DMS Pharmaceutical Group supplies both routine and critical medications, including branded and generic...